Sugiko Watanabe

Sugiko Watanabe

Auto-generated profile, based on publicly available information

Sugiko Watanabe

Innovative Anticancer Strategy for Therapeutics and Diagnosis Group, Innovation Center for Medical Redox Navigation, Kyushu University, Fukuoka, Kyushu, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ATAkiko Takahashi
Akiko Takahashi
RORyo Okada
Ryo Okada
KNKoji Nagao
Koji Nagao
YKYuka Kawamata
Yuka Kawamata
AHAki Hanyu
Aki Hanyu
EHEiji Hara
Eiji Hara
Emerging evidence is revealing that exosomes contribute to many aspects of physiology and disease through intercellular communication. However, the biological roles of exosome secretion in exosome-secreting cells have remained largely unexplored. Here we show that exosome secretion plays a crucial role in maintaining cellular homeostasis in exosome-secreting cells. The inhibition of exosome secretion results in the accumulation of nuclear DNA in the cytoplasm, thereby causing the activation of cytoplasmic DNA sensing machinery. This event provokes the innate immune response, leading to reactive oxygen species (ROS)-dependent DNA damage response and thus induce senescence-like cell-cycle arrest or apoptosis in normal human cells. These results, in conjunction with observations that exosomes contain various lengths of chromosomal DNA fragments, indicate that exosome secretion maintains cellular homeostasis by removing harmful cytoplasmic DNA from cells. Together, these findings enhance our understanding of exosome biology, and provide valuable new insights into the control of cellular homeostasis.

6 June 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MTMasaki Takasugi
Masaki Takasugi
RORyo Okada
Ryo Okada
ATAkiko Takahashi
Akiko Takahashi
DCDavid Virya Chen
David Virya Chen
SWSugiko Watanabe
Sugiko Watanabe
EHEiji Hara
Eiji Hara
Cellular senescence prevents the proliferation of cells at risk for neoplastic transformation. However, the altered secretome of senescent cells can promote the growth of the surrounding cancer cells. Although extracellular vesicles (EVs) have emerged as new players in intercellular communication, their role in the function of senescent cell secretome has been largely unexplored. Here, we show that exosome-like small EVs (sEVs) are important mediators of the pro-tumorigenic function of senescent cells. sEV-associated EphA2 secreted from senescent cells binds to ephrin-A1, that is, highly expressed in several types of cancer cells and promotes cell proliferation through EphA2/ephrin-A1 reverse signalling. sEV sorting of EphA2 is increased in senescent cells because of its enhanced phosphorylation resulting from oxidative inactivation of PTP1B phosphatase. Our results demonstrate a novel mechanism of reactive oxygen species (ROS)-regulated cargo sorting into sEVs, which is critical for the potentially deleterious growth-promoting effect of the senescent cell secretome.

28 March 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ATAkiko Takahashi
Akiko Takahashi
TLTZE MUN LOO
TZE MUN LOO
RORyo Okada
Ryo Okada
FKFumitaka Kamachi
Fumitaka Kamachi
YWYoshihiro Watanabe
Yoshihiro Watanabe
EHEiji Hara
Eiji Hara
Accumulating evidence indicates that the senescence-associated secretory phenotype (SASP) contributes to many aspects of physiology and disease. Thus, controlling the SASP will have tremendous impacts on our health. However, our understanding of SASP regulation is far from complete. Here, we show that cytoplasmic accumulation of nuclear DNA plays key roles in the onset of SASP. Although both DNase2 and TREX1 rapidly remove the cytoplasmic DNA fragments emanating from the nucleus in pre-senescent cells, the expression of these DNases is downregulated in senescent cells, resulting in the cytoplasmic accumulation of nuclear DNA. This causes the aberrant activation of cGAS-STING cytoplasmic DNA sensors, provoking SASP through induction of interferon-β. Notably, the blockage of this pathway prevents SASP in senescent hepatic stellate cells, accompanied by a decline of obesity-associated hepatocellular carcinoma development in mice. These findings provide valuable new insights into the roles and mechanisms of SASP and possibilities for their control.

18 April 2017 in Cancer Science
Verified
Journal Article
Open access
PDF file
SWSugiko Watanabe
Sugiko Watanabe
SKShimpei Kawamoto
Shimpei Kawamoto
NONaoko Ohtani
Naoko Ohtani
EHEiji Hara
Eiji Hara
“Cellular senescence” is a state in which cells undergo irreversible cell cycle arrest in response to a variety of cellular stresses. Once cells senesce, they are strongly resistant to any mitogens, including oncogenic stimuli. Therefore, cellular senescence has been assumed to be a potent anticancer mechanism. Although irreversible cell‐cycle arrest is traditionally considered the major characteristic of senescent cells, recent studies have revealed some additional functions. Most noteworthy is the increased secretion of various secretory proteins, such as inflammatory cytokines, chemokines, growth factors, and MMPs, into the surrounding extracellular fluid. These newly recognized senescent phenotypes, termed senescence‐associated secretory phenotypes (SASPs), reportedly contribute to tumor suppression, wound healing, embryonic development, and even tumorigenesis promotion. Thus, SASPs appear to be beneficial or deleterious, depending on the biological context. As senescent cells are known to accumulate during the aging process in vivo, it is quite possible that their accumulation in aged tissues promotes age‐associated functional decline and various diseases, including cancers, at least to some extent. Here, we focus on and discuss the functional and regulatory network of SASPs toward opening up new possibilities for controlling aging and aging‐associated diseases.

1 June 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
NFNaoyuki Fujita
Naoyuki Fujita
SWSugiko Watanabe
Sugiko Watanabe
TITakaya Ichimura
Takaya Ichimura
STShu Tsuruzoe
Shu Tsuruzoe
YSYoichi Shinkai
Yoichi Shinkai
MNMitsuyoshi Nakao
Mitsuyoshi Nakao
Cytosine methylation and posttranslational modifications of the amino termini of the core histones in the nucleosome provide epigenetic codes for genome regulation. In the nucleus, not only is the DNA methylated, but the methylated DNA is also interpreted by methyl-CpG binding domain (MBD) proteins. MBD1 possesses an MBD involved in mediating DNA methylation-dependent transcriptional repression. The MBD of MBD1 binds a symmetrically methylated CpG sequence, but the precise roles of this domain have not been investigated. In addition, little is understood about the state of histone modifications within MBD1-containing heterochromatin on methylated gene promoters. Here we show that histone H3 methylase Suv39h1 and the methyl lysine-binding protein HP1 directly interact with MBD of MBD1 in vitro and in cells. Suv39h1 was found to enhance MBD1-mediated transcriptional repression via MBD but not via the C-terminal transcriptional repression domain of MBD1. Furthermore, MBD1 links to histone deacetylases through Suv39h1, resulting in methylation and deacetylation of histones for gene inactivation. These data indicate that MBD1 may tether the Suv39h1-HP1 complex to methylated DNA regions, suggesting the presence of a pathway from DNA methylation to the modifications of histones for epigenetic gene regulation.

1 March 2009 in The American Journal of Pathology
Verified
Journal Article
Closed access
SWSugiko Watanabe
Sugiko Watanabe
YUYasuaki Ueda
Yasuaki Ueda
SAShin-Ichi Akaboshi
Shin-Ichi Akaboshi
YHYuko Hino
Yuko Hino
YSYoko Sekita
Yoko Sekita
MNMitsuyoshi Nakao
Mitsuyoshi Nakao